Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-human Legumain protein monoclonal antibody, hybridoma cell strain LGMN-2 and applications thereof

一种杂交瘤细胞株、LGMN-2的技术，应用在抗酶免疫球蛋白、生物化学设备和方法、仪器等方向，能够解决应用还属空白、没有检测方法等问题，达到好特异性的效果

Inactive Publication Date: 2019-04-30
李伟 +1
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] As a new biological indicator, Legumain has no clinical detection method for it at present, and its application in monitoring the occurrence and development of tumors is still blank

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-human Legumain protein monoclonal antibody, hybridoma cell strain LGMN-2 and applications thereof
  • Anti-human Legumain protein monoclonal antibody, hybridoma cell strain LGMN-2 and applications thereof
  • Anti-human Legumain protein monoclonal antibody, hybridoma cell strain LGMN-2 and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1, prepare the monoclonal antibody of anti-human Legumain protein

[0032] 1. Preparation of Legumain antigen

[0033] 1) Obtaining the sequence of the Legumain gene

[0034] The gene encoding Legumain is located on human chromosome 14 (14q32.12), and its sequence number in the NCBI database is CCDS: CCDS9904.1. The plasmid pLEXSY-sat2-hLGMN carrying the human Legumain gene was donated by Dr. Elfriede Dall from the University of Salzburg, Austria. The non-patent literature that has recorded the eukaryotic expression plasmid pLEXSY-sat2-hLGMN is E. Dall and H. Brandstetter, Activation of legumain involves proteolytic and conformational events, resulting in a context-and substrate-dependent activity profile., Acta Crystallogr Sect F Struct Biol Crystal Commun. 2012 Jan 1;68(Pt 1):24–31.

[0035] 2) Construction and identification of recombinant plasmids

[0036] In order to make human Legumain secreted outside the cell after expression, a tissue-type plasmin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an anti-human Legumain protein monoclonal antibody, a hybridoma cell strain LGMN-2 and applications thereof. The name of provided hybridoma cell strain is LGMN-2, and the preservation number is CGMCC No.12995. The provided anti-human Legumain protein monoclonal antibody is secreted by the hybridoma cell strain LGMN-2 with a preservation number of CGMCC No.12995. The provided monoclonal antibody has a high titer, and the maximal indirect method titer can reach 1:2.56*10<8>. There is no cross reaction between the monoclonal antibody and Legumain proteins: Cathepsin B, Cathepsin H, and Cathepsin L; and the specificity is good.

Description

technical field [0001] The invention relates to the technical field of biomedical engineering, in particular to a monoclonal antibody against human Legumain protein, a hybridoma cell line LGMN-2 and uses thereof. Background technique [0002] Legumain (C13) (EC 3.4.22.34), also known as asparaginyl endopeptidase (AEP), is a lysozyme cysteine ​​protease and a new member of the cysteine ​​protease C13 family. The human Legumain gene is located on chromosome 14, encoding a polypeptide chain composed of 433 amino acid residues, which becomes a biologically active mature enzyme after deglycosylation, and has 83% homology with mice. Human legumain protein has 3 forms, namely 56kD zymogen precursor, 46kD and 36kD mature enzyme. The active catalytic center of Legumain is a catalytic duplex composed of histidine (His) and cysteine ​​(Cys), which is necessary for Legumain to exert its catalytic activity and is also a necessary structure for every C13 family member. [0003] Compared...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/20C07K16/40G01N33/577G01N33/573
CPCC07K16/40G01N33/573G01N33/577G01N2333/96466
Inventor 李伟
Owner 李伟
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com